Use access key #2 to skip to page content.
$52.36 -0.42 (-0.80%)
7/18/2008 4:00 PM

Allergan, Inc. (AGN)

CAPS Rating:
****

A technology-driven, global health care company which discovers, develops and commercializes pharmaceutical and medical device products for markets such as ophthalmic, neurological, medical aesthetics, medical dermatological etc.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating AGN

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

264 Outperforms
22 Underperforms
 

All-Stars

87 Outperforms
4 Underperforms
 

Wall Street

7 Outperforms
1 Underperforms
 

Players bullish on AGN are also bullish on:

Players bearish on AGN are also bearish on:

Ticker Tags

Large Cap (467), Six Sigma® (37), S&P 500 (481), Drug Manufacturers - Other (105)
Suggest a tag

Allergan, Inc. At A Glance

Current Price: $52.36
Last Trade Time: 7/18/2008 4:00 PM
Open: $51.93
Previous Close: $52.78
Daily Range: $51.51 - $52.60
52-Week Range: $50.21 - $70.40
Volume: 2,969,692
Market Cap: $16.10B
P/E Ratio: 28.38
Compare Our Special Broker Offers!

Stock Trends

AGN VS S&P 500 (SPY)

AGN 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for AGN

More Headlines...

Top Bull Pitch

Recs

4

Allergan, Inc. (AGN)

Avatar xthecritic (96.80) Submitted: 2/08/08 2:17 PM

Great company with exposure to healthcare company with pharma and device products. Oh, and they make Botox. Botox is mainstream now. The company has been going gang busters for the last few years. News hit today that the FDA is reviewing the safety of Botox and the stock is off 5%. Great chance...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Allergan, Inc. (AGN)

Avatar jbparis1 (73.14) Submitted: 1/30/08 8:56 PM

Allergan has too much liability with Botox. The recent deaths that are supposedly connected to injections will cause more problems for Allergan. The use of Botox will continue to grow for the next year, but legal issues will drain investor confidence and pave the way for class action lawsuits.
Als...More

Replies: 1 | Reply | Permalink

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 48 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (AGN)

Avatar JoyofMoney (< 20) Submitted: 7/09/08 2:32 AM : Outperform Start Price: $52.37 AGN Score: 2.22

Terrible P/E ratios but the rest of the fundamentals were good enough to sell me. Medical devices, a complement to pharmaceutical as well as a specialty pharmaceutical niche. Had narrow movement in stock price in the past few weeks and I liked the price being toward its 52 week low. Optimistically, I am looking for strength out of this one in a market that is volatile.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AGN)

Avatar lonewulf47638 (63.33) Submitted: 7/08/08 11:43 AM : Outperform Start Price: $51.16 AGN Score: 1.70

Bot is reached and stock will rise with Botox..

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AGN)

Avatar chk999longonly (98.40) Submitted: 6/28/08 8:42 PM : Outperform Start Price: $51.76 AGN Score: 2.63

This hit a 52 week low.

This is a bet that the market for this companies products will pick up once the economy does.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AGN)

Avatar biovestor (74.58) Submitted: 6/28/08 10:29 AM : Outperform Start Price: $51.76 AGN Score: 2.63

A leader in cosmetic medicine in a US market obsessed with appearance and a growing Baby Boomer population.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (AGN)

Avatar eslavs (< 20) Submitted: 6/23/08 9:17 PM : Underperform Start Price: $52.86 AGN Score: -2.96

I work in ophthalmology, and I see a segment of this company's products. In our industry, most are top-notch. However, looking ahead to uncertain economic times, increased competition and possible regulation, I don't think Botox is going to be as hot a product as it has been. My bet is Allergan will continue to slide.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 48 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 8 of 8  

picks per page. CHANGE Expand All Pitches

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackEdwardOwens 98.95 06/13/08 06/13/08 Outperform 1Y $56.81-7.83%-6.28%-1.55 Toggle the visibility of 60-Second Pitch and replies
TrackDodgeCox 98.58 09/30/07 09/30/07 Outperform NS $64.31-18.59%-17.39%-1.20 Toggle the visibility of 60-Second Pitch and replies
TrackWachovia 78.21 07/11/07 07/11/07 Outperform NS $58.01-9.74%-16.38%+6.64
TrackLazardCapit 78.47 05/29/07 05/29/07 Outperform NS $61.39-14.71%-17.21%+2.51
TrackMatrix 89.88 05/24/07 05/24/07 Underperform NS $60.08-12.85%-17.36%-4.51
TrackMerrimanCo < 20 04/17/07 04/17/07 Outperform NS $58.89-11.09%-14.23%+3.15
TrackBofASec 96.91 11/20/06 11/20/06 Outperform NS $58.35-10.27%-10.12%-0.15
TrackJimCramer 82.55 09/05/06 09/05/06 Outperform 3W $56.53-7.38%-4.32%-3.06

Results 1 - 8 of 8  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners